Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment of Multiple Sclerosis With Copaxone and Albuterol
This study is ongoing, but not recruiting participants.
Study NCT00039988 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: June 18, 2002 Last Updated: September 26, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autoimmune Diseases
Multiple Sclerosis
Additional conditions recognized in this trial
Sclerosis
More general conditions related to this trial
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
Interventions listed in this trial
Glatiramer acetate
Albuterol
Albuterol placebo
Additional drug interventions recognized in this trial
Copolymer 1
More general drug interventions related to this trial
Adjuvants, Immunologic
Adrenergic Agents
Adrenergic Agonists
Adrenergic beta-Agonists
Anti-Asthmatic Agents
Autonomic Agents
Bronchodilator Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Respiratory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Autoimmunity Centers of Excellence
Back to top of Main Content
